Target intelligence / Profile preview

Pseudogene similar to part of nucleolar protein 5 Nol5 (null)

Target
null
Molecular classification
Other (Pseudogene)
01

Overview

This entity is a pseudogene, meaning it is a non-functional genetic sequence resembling a portion of the nucleolar protein 5 (Nol5) gene, but lacking protein-coding capability due to mutations or sequence defects. Pseudogenes can have high sequence similarity to functional genes ("parental genes"), but acquire mutations (frameshifts, premature stop codons) that prevent them from encoding functional protein products. Recent research has revealed that some pseudogenes can regulate the expression of related genes by producing noncoding RNAs, acting as decoys for regulatory elements, or influencing epigenetic silencing, though many remain transcriptionally silent or of unknown function. There is no evidence that ENSG00000228471 acts as a receptor, enzyme, transporter, or in any direct molecular mechanism relevant for drug targeting. Its pharmacological, clinical, and biomarker relevance is presently null. This gene should not be considered a classical molecular target, and any search for receptor, transporter, or enzyme activity, disease association, or drug interaction is unsupported for ENSG00000228471.

Other names
Pseudogene similar to part of nucleolar protein 5 Nol5ENSG00000228471
02

Mechanism of action

Not applicable (no drug mechanisms)

03

Biological functions

May exert regulatory functions through noncoding RNA products, e.g., antisense RNA, lncRNA, or siRNA, affecting gene expression of related protein-coding genesNo evidence for direct roles in classical signaling, metabolic, or transport processes
04

Disease associations

Pseudogenes as a class may contribute to gene regulation in diseases, including cancer (via regulatory RNAs), but no specific disease association for this pseudogene

Beyond the preview

Go deeper on Pseudogene similar to part of nucleolar protein 5 Nol5 (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of nucleolar protein 5 Nol5 (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call